Biomarkers in neonatal encephalopathy: the role of high-mobility group box 1 in prognosis and potential therapy
Crossref DOI link: https://doi.org/10.1038/s41390-025-04309-1
Published Online: 2025-09-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Molloy, Eleanor J. https://orcid.org/0000-0001-6798-2158
Text and Data Mining valid from 2025-09-10
Version of Record valid from 2025-09-10
Article History
Received: 8 November 2024
Revised: 3 April 2025
Accepted: 12 April 2025
First Online: 10 September 2025
Competing interests
: The authors declare no competing interests.